B4GALNT1 (beta-1,4 N-acetylgalactosaminyltransferase 1; GM2/GD2 synthase; GalNAc-T; EC 2.4.1.92) is a Golgi-resident, single-pass type II membrane glycosyltransferase of CAZy family GT12 that catalyzes the committed step of complex ganglioside biosynthesis. It transfers N-acetylgalactosamine in beta-1,4 linkage from UDP-GalNAc onto the ganglioside precursors GM3, GD3 and GT3 (and onto neutral lactosylceramide) to produce GM2, GD2, GT2 and GA2 (asialo-GM2), releasing UDP. This activity is the branch point that channels GM3/GD3 into the a-, b- and o-series of complex gangliosides, which are enriched in the nervous system and are components of the synaptic plasma membrane. The enzyme functions as a disulfide-linked homodimer with antiparallel catalytic domains. Loss-of-function variants cause autosomal recessive hereditary spastic paraplegia type 26 (SPG26), a complicated spastic paraplegia with intellectual disability and additional neurological features, linking impaired complex-ganglioside synthesis to neurodegeneration.
| GO Term | Evidence | Action | Reason |
|---|---|---|---|
| GO:0008376 acetylgalactosaminyltransferase activity | IBA GO_REF:0000033 | KEEP AS NON CORE | Summary: Correct but general parent of the specific activity. B4GALNT1 is a GalNAc-transferase, so acetylgalactosaminyltransferase activity is accurate; the informative molecular function is the ganglioside GalNAc-transferase term GO:0003947. Keep as a valid family-level (phylogenetic) call but not the core function. Reason: Accurate but one branch above the specific GM3/GD3 GalNAc-transferase activity that defines this enzyme; GO:0003947 is the informative core MF. |
| GO:0001574 ganglioside biosynthetic process | IBA GO_REF:0000033 | ACCEPT | Summary: Correct core biological process. B4GALNT1 performs the committed GalNAc-transfer step of complex ganglioside biosynthesis. The phylogenetic (IBA) call agrees with the human experimental IDA/IMP annotations to the same term. |
| GO:0000139 Golgi membrane | IEA GO_REF:0000120 | ACCEPT | Summary: Correct subcellular location. B4GALNT1 is a single-pass type II Golgi-membrane protein, consistent with UniProt and with the ISS/TAS annotations to the same term. |
| GO:0003947 (N-acetylneuraminyl)-galactosylglucosylceramide N-acetylgalactosaminyltransferase activity | IEA GO_REF:0000120 | ACCEPT | Summary: This is the precise, informative molecular function of B4GALNT1 (the GM3->GM2 / GD3->GD2 GalNAc-transferase step, EC 2.4.1.92). Well supported experimentally (IDA/IMP) in the same annotation set; the electronic call is redundant-but-correct. |
| GO:0008376 acetylgalactosaminyltransferase activity | IEA GO_REF:0000117 | KEEP AS NON CORE | Summary: ARBA electronic annotation to the correct-but-general parent term. Accurate, but the specific GO:0003947 term better captures the function; retained as non-core. Reason: General parent of the specific ganglioside GalNAc-transferase activity. |
| GO:0016758 hexosyltransferase activity | IEA GO_REF:0000002 | MARK AS OVER ANNOTATED | Summary: InterPro2GO electronic annotation to a very general parent (hexosyltransferase activity). Not wrong - GalNAc transfer is a hexosaminyltransfer reaction - but far less informative than GO:0003947/GO:0008376. Flagged as over-general. Reason: Two-plus branches above the specific ganglioside GalNAc-transferase activity; adds little beyond the more specific transferase terms already annotated. |
| GO:1901135 carbohydrate derivative metabolic process | IEA GO_REF:0000117 | MARK AS OVER ANNOTATED | Summary: Very general ARBA electronic process term. Technically consistent with a UDP-GalNAc-using glycosyltransferase, but uninformative relative to the specific ganglioside biosynthetic process (GO:0001574) already annotated. Reason: High-level catch-all process; subsumed by the specific ganglioside biosynthetic process. |
| GO:0001574 ganglioside biosynthetic process | IEA GO_REF:0000107 | ACCEPT | Summary: Ensembl-orthology electronic transfer of the correct core biological process. Consistent with the human experimental annotations to the same term. |
| GO:0000139 Golgi membrane | ISS GO_REF:0000024 | ACCEPT | Summary: Correct Golgi-membrane localization transferred by sequence similarity from the mouse ortholog (Q10468). Consistent with the type II Golgi-membrane topology in UniProt. |
| GO:0001574 ganglioside biosynthetic process | IDA PMID:7487055 Analysis of melanoma cells stably transfected with beta 1,4G... | ACCEPT | Summary: Direct experimental support. Membrane preparations from B4GALNT1 transfectants showed de novo synthesis of GM2 and GD2 from GM3 and GD3 acceptors, and B4GALNT1 levels controlled overall cellular ganglioside composition (a- vs b-series). Core biological process. Supporting Evidence: PMID:7487055 synthesis of GM2 or GD2 in in vitro assays using GM3 or GD3, respectively |
| GO:0001574 ganglioside biosynthetic process | IDA PMID:7890749 Substrate specificity of beta 1,4-N-acetylgalactosaminyltran... | ACCEPT | Summary: Direct experimental support. Substrate-specificity study showed the enzyme generates GM2, GD2 and additional gangliosides (asialo-GM2, GalNAc-GD1a) from appropriate acceptors, establishing its role in ganglioside biosynthesis. Core biological process. Supporting Evidence: PMID:7890749 GM2/GD2 synthase efficiently generates asialo-GM2 in |
| GO:0003947 (N-acetylneuraminyl)-galactosylglucosylceramide N-acetylgalactosaminyltransferase activity | IDA PMID:7487055 Analysis of melanoma cells stably transfected with beta 1,4G... | ACCEPT | Summary: Direct experimental support for the specific GM3->GM2 (and GD3->GD2) GalNAc-transferase activity: in vitro assays of transfectant membranes synthesized GM2/GD2 de novo from GM3/GD3. This is the core molecular function. Supporting Evidence: PMID:7487055 synthesis of GM2 or GD2 in in vitro assays using GM3 or GD3, respectively |
| GO:0003947 (N-acetylneuraminyl)-galactosylglucosylceramide N-acetylgalactosaminyltransferase activity | IDA PMID:7890749 Substrate specificity of beta 1,4-N-acetylgalactosaminyltran... | ACCEPT | Summary: Direct experimental support. The purified fusion enzyme and transfectant extracts transferred GalNAc onto GM3/GD3 (and other acceptors) to make GM2/GD2, defining the specific ganglioside GalNAc-transferase activity. Core molecular function. Supporting Evidence: PMID:7890749 asialo-GM2, GalNAc-sialylparagloboside, and Gal-NAc-GD1a from |
| GO:0005794 Golgi apparatus | ISS GO_REF:0000024 | KEEP AS NON CORE | Summary: Correct but less specific than Golgi membrane. B4GALNT1 is a Golgi-membrane-integral type II protein; GO:0000139 (Golgi membrane) is the more precise and preferred CC term. Reason: Parent of the more specific Golgi membrane localization already annotated. |
| GO:0001574 ganglioside biosynthetic process | IMP PMID:1601877 Expression cloning of beta 1,4 N-acetylgalactosaminyltransfe... | ACCEPT | Summary: Direct experimental support from the original expression cloning: the cloned cDNA, when stably transfected, determined GM2/GD2 ganglioside expression in melanoma cells, catalyzing GalNAc transfer onto GM3 and GD3. Core biological process. Supporting Evidence: PMID:1601877 catalyze the transfer of GalNAc onto GM3 and GD3 by a beta 1,4 |
| GO:0003947 (N-acetylneuraminyl)-galactosylglucosylceramide N-acetylgalactosaminyltransferase activity | IMP PMID:1601877 Expression cloning of beta 1,4 N-acetylgalactosaminyltransfe... | ACCEPT | Summary: Direct experimental support. Expression cloning identified the cDNA as the UDP-GalNAc:GM3/GD3 beta-1,4 N-acetylgalactosaminyltransferase (EC 2.4.1.92), transferring GalNAc onto GM3/GD3 to form GM2/GD2. This is the core molecular function. Supporting Evidence: PMID:1601877 N-acetylgalactosaminyltransferase (EC 2.4.1.92) gene |
| GO:0000139 Golgi membrane | TAS Reactome:R-HSA-8856223 | ACCEPT | Summary: Correct Golgi-membrane localization from the Reactome reaction "B4GALNT1 dimer transfers GalNAc to gangliosides", which describes the homodimeric enzyme residing on the Golgi membrane. Consistent with all other localization annotations. |
| GO:0003947 (N-acetylneuraminyl)-galactosylglucosylceramide N-acetylgalactosaminyltransferase activity | TAS PMID:8702839 Genomic organization and chromosomal assignment of the human... | ACCEPT | Summary: Traceable author statement to the specific ganglioside GalNAc-transferase activity. The cited paper is on genomic organization but describes the beta1,4GalNAc-T (EC 2.4.1.92) enzyme; the activity itself is directly established by the IDA/IMP annotations. Correct core MF. |
| GO:0005975 carbohydrate metabolic process | TAS PMID:1601877 Expression cloning of beta 1,4 N-acetylgalactosaminyltransfe... | MARK AS OVER ANNOTATED | Summary: Correct but very general (ProtInc legacy TAS). Ganglioside/glycosphingolipid biosynthesis is a specialized carbohydrate metabolic process; the specific GO:0001574 is far more informative. Reason: High-level metabolic term subsumed by the specific ganglioside biosynthetic process. |
| GO:0006687 glycosphingolipid metabolic process | TAS PMID:1601877 Expression cloning of beta 1,4 N-acetylgalactosaminyltransfe... | KEEP AS NON CORE | Summary: Correct - gangliosides are glycosphingolipids, so B4GALNT1 participates in glycosphingolipid metabolism (UniProt PATHWAY: Sphingolipid metabolism; Reactome: Glycosphingolipid biosynthesis). More general than the specific ganglioside biosynthetic process; retained as an accurate non-core parent. Reason: Accurate parent process of ganglioside biosynthesis. |
| GO:0016020 membrane | TAS PMID:1601877 Expression cloning of beta 1,4 N-acetylgalactosaminyltransfe... | MARK AS OVER ANNOTATED | Summary: Correct but uninformatively general (ProtInc legacy TAS reflecting the type II transmembrane topology). Golgi membrane (GO:0000139) captures the same information specifically. Reason: Bare membrane term subsumed by the specific Golgi membrane localization. |
Loading supporting content…
Download this section (compressed HTML)Q: How do the SPG26 missense variants (R300C, D433A) impair activity - by disrupting catalysis, homodimerization/disulfide bonding, or Golgi localization - and does this differentially affect the a-, b- and o-series ganglioside outputs?
Q: What determines the in vivo preference among B4GALNT1 acceptors (GM3 vs GD3 vs LacCer) in neurons, and how does competition with sialyltransferases set the a/b/o-series balance in the nervous system?
Experiment: Structure-guided and glycomic characterization of SPG26 variants: express R300C and D433A in a B4GALNT1-null cell line and measure GM2/GD2/GA2 output, dimer formation, and Golgi retention to define the pathogenic mechanism.
Experiment: Quantitative acceptor-competition assays (GM3, GD3, GT3, LacCer) with recombinant B4GALNT1 to define kinetic preferences and reconcile the low-efficiency acceptors seen in vitro with the dominant GM2/GD2 products in vivo.
Loading supporting content…
Download this section (compressed HTML)Loading supporting content…
Download this section (compressed HTML)